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 Comment on  Pyrexia of unknown origin 
 Editor – The CME section on infectious diseases contained a most 
interesting article by Fernandez and Beeching on the important 
subject of pyrexia of unknown origin. 1 However, I feel that there 
was one important area that they failed to address, namely 
how temperature should actually be measured. This is especially 
important in identifying cases of factitious fever, a topic which they 
listed but did not actually address, but which may be an important 
feature of Munchausen’s syndrome (and Munchausen’s syndrome by 
proxy). I recall being taught as a student of the value of measuring 
the temperature of freshly passed urine as being a method that 
circumvented patient’s attempts at artefactually tampering with 
temperature measurement, and which could also be used in restless 
or uncooperative individuals; but perhaps the authors might be 
invited to tell us how things should be done in the modern era. ■ 
 BARRY MONK 
 Consultant dermatologist, Manor Hospital, 
Biddenham, Bedfordshire, UK 
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 Response 
 Thank you for this interesting commentary and insight on our 
review. As you imply, it is essential that all investigations and 
clinical observations, such as measuring core temperature, are 
carried out in a manner that is tamper-proof. In the past it was 
not uncommon for patients to generate artefactually raised 
temperatures by placing their thermometer on the radiator, in 
a hot cup of tea, or under a hot tap. In most British hospitals 
temperatures are now measured electronically under direct 
observation at the same as recording other vital signs, so this 
reduces the risk of falsiﬁcation of temperature. ■ 
 CRISTINA FERNANDEZ 
 Specialist trainee, Royal Liverpool University Hospital, 
Liverpool, UK 
 NICK J BEECHING 
 Senior lecturer and honorary consultant, Royal Liverpool 
University Hospital and Liverpool School of Tropical Medicine, 
Liverpool, UK 
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 Importance of CSF lactate concentration in the 
diagnosis of acute bacterial meningitis 
 Editor – We read with interest the recent  Clinical Medicine 
review by Grifﬁths  et al 1 on management of acute meningitis, 
but were disappointed to note that there was no reference to 
the importance of biochemical analysis of cerebrospinal ﬂuid 
(CSF) lactate concentration in the diagnosis of acute bacterial 
meningitis (ABM). 
 A CSF lactate concentration of >3.8 mmol/L reliably discriminates 
between viral/aseptic meningitis and ABM, 2–4 and a recent UK 
consensus guideline on management of acute meningitis in adults 
recommends analysis of CSF lactate in these patients. 5 Co-authors 
of Grifﬁths’ review paper in  Clin Med (McGill and Solomon) were 
also named contributors to this guideline. 
 Measurement of CSF lactate is quick and inexpensive, and 
can be performed on the same CSF sample taken in the ﬂuoride 
(grey-top) tube, which is also used to measure CSF glucose 
concentration. 
 When taken expeditiously from a patient with suspected acute 
meningitis prior to receipt of antimicrobial therapy, the combination 
of a negative CSF microscopy / Gram’s stain and a CSF lactate 
concentration result of <3.8 mmol/L can safely allow clinicians to 
discontinue antibacterial meningitis treatment. This is particularly 
relevant in patients admitted to smaller district general hospitals, 
which often do not have access to on-site polymerase chain reaction 
(PCR) assays or virology laboratory services. ■ 
 EAMON P MCCARRON 
 Specialty doctor in general medicine, South West Acute Hospital, 
Enniskillen, Northern Ireland, UK 
 SHIVA SREENIVASAN 
 Consultant in acute medicine, South West Acute Hospital, 
Enniskillen,  Northern Ireland, UK 
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